nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—PTGS1—esophageal cancer	0.249	0.486	CbGaD
Salicylic acid—PTGS2—esophageal cancer	0.142	0.278	CbGaD
Salicylic acid—ABCB1—esophageal cancer	0.121	0.236	CbGaD
Salicylic acid—SLC16A1—Methotrexate—esophageal cancer	0.105	0.263	CbGbCtD
Salicylic acid—SLC22A11—Methotrexate—esophageal cancer	0.0543	0.136	CbGbCtD
Salicylic acid—SLC22A7—Methotrexate—esophageal cancer	0.0517	0.129	CbGbCtD
Salicylic acid—PTGS2—Cisplatin—esophageal cancer	0.0458	0.114	CbGbCtD
Salicylic acid—SLC22A8—Methotrexate—esophageal cancer	0.0316	0.0788	CbGbCtD
Salicylic acid—CYP2C9—Capecitabine—esophageal cancer	0.0309	0.0771	CbGbCtD
Salicylic acid—SLC22A6—Methotrexate—esophageal cancer	0.022	0.0549	CbGbCtD
Salicylic acid—ALB—Methotrexate—esophageal cancer	0.0187	0.0468	CbGbCtD
Salicylic acid—CYP2C9—Cisplatin—esophageal cancer	0.0156	0.0388	CbGbCtD
Salicylic acid—ABCB1—Cisplatin—esophageal cancer	0.0151	0.0377	CbGbCtD
Salicylic acid—ABCB1—Methotrexate—esophageal cancer	0.0098	0.0245	CbGbCtD
Salicylic acid—Acetylsalicylic acid—HSPA5—esophageal cancer	0.00152	0.233	CrCbGaD
Salicylic acid—Localized exfoliation—Capecitabine—esophageal cancer	0.00076	0.0894	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—TP53—esophageal cancer	0.000627	0.0961	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS1—esophageal cancer	0.000492	0.0755	CrCbGaD
Salicylic acid—Gastric ulcer—Capecitabine—esophageal cancer	0.000352	0.0414	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS1—esophageal cancer	0.000337	0.0517	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS1—esophageal cancer	0.000317	0.0486	CrCbGaD
Salicylic acid—Diflunisal—PTGS1—esophageal cancer	0.000317	0.0486	CrCbGaD
Salicylic acid—Hearing impaired—Cisplatin—esophageal cancer	0.000292	0.0343	CcSEcCtD
Salicylic acid—Pain—Carboplatin—esophageal cancer	0.000289	0.034	CcSEcCtD
Salicylic acid—Salsalate—PTGS1—esophageal cancer	0.000287	0.044	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS1—esophageal cancer	0.000283	0.0434	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS2—esophageal cancer	0.000281	0.0432	CrCbGaD
Salicylic acid—Skin exfoliation—Cisplatin—esophageal cancer	0.000265	0.0312	CcSEcCtD
Salicylic acid—Mesalazine—PTGS1—esophageal cancer	0.000249	0.0382	CrCbGaD
Salicylic acid—Deafness—Cisplatin—esophageal cancer	0.000225	0.0265	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS1—esophageal cancer	0.00022	0.0337	CrCbGaD
Salicylic acid—Burning sensation—Methotrexate—esophageal cancer	0.000219	0.0258	CcSEcCtD
Salicylic acid—Hearing impaired—Capecitabine—esophageal cancer	0.000215	0.0253	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS1—esophageal cancer	0.000214	0.0329	CrCbGaD
Salicylic acid—Skin exfoliation—Capecitabine—esophageal cancer	0.000195	0.023	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS2—esophageal cancer	0.000193	0.0296	CrCbGaD
Salicylic acid—Oesophagitis—Capecitabine—esophageal cancer	0.000187	0.022	CcSEcCtD
Salicylic acid—Ecchymosis—Capecitabine—esophageal cancer	0.000185	0.0218	CcSEcCtD
Salicylic acid—Diflunisal—PTGS2—esophageal cancer	0.000181	0.0278	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS2—esophageal cancer	0.000181	0.0278	CrCbGaD
Salicylic acid—Abdominal discomfort—Cisplatin—esophageal cancer	0.000167	0.0197	CcSEcCtD
Salicylic acid—Deafness—Capecitabine—esophageal cancer	0.000166	0.0195	CcSEcCtD
Salicylic acid—Salsalate—PTGS2—esophageal cancer	0.000164	0.0251	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS2—esophageal cancer	0.000162	0.0248	CrCbGaD
Salicylic acid—Lethargy—Capecitabine—esophageal cancer	0.000152	0.0178	CcSEcCtD
Salicylic acid—Skin exfoliation—Methotrexate—esophageal cancer	0.000145	0.0171	CcSEcCtD
Salicylic acid—Mesalazine—PTGS2—esophageal cancer	0.000142	0.0218	CrCbGaD
Salicylic acid—Ecchymosis—Methotrexate—esophageal cancer	0.000138	0.0162	CcSEcCtD
Salicylic acid—Abdominal pain upper—Capecitabine—esophageal cancer	0.000136	0.016	CcSEcCtD
Salicylic acid—Tinnitus—Cisplatin—esophageal cancer	0.00013	0.0153	CcSEcCtD
Salicylic acid—Asthma—Capecitabine—esophageal cancer	0.000128	0.0151	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS2—esophageal cancer	0.000126	0.0193	CrCbGaD
Salicylic acid—Abdominal discomfort—Capecitabine—esophageal cancer	0.000123	0.0145	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS2—esophageal cancer	0.000123	0.0188	CrCbGaD
Salicylic acid—Erythema—Cisplatin—esophageal cancer	0.000121	0.0143	CcSEcCtD
Salicylic acid—Weight increased—Capecitabine—esophageal cancer	0.000117	0.0138	CcSEcCtD
Salicylic acid—Lethargy—Methotrexate—esophageal cancer	0.000113	0.0133	CcSEcCtD
Salicylic acid—Epistaxis—Capecitabine—esophageal cancer	0.000108	0.0127	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ABCB1—esophageal cancer	0.000104	0.016	CrCbGaD
Salicylic acid—Hepatitis—Capecitabine—esophageal cancer	0.000103	0.0121	CcSEcCtD
Salicylic acid—Oedema—Cisplatin—esophageal cancer	9.91e-05	0.0117	CcSEcCtD
Salicylic acid—Erythema multiforme—Capecitabine—esophageal cancer	9.72e-05	0.0114	CcSEcCtD
Salicylic acid—Tinnitus—Capecitabine—esophageal cancer	9.59e-05	0.0113	CcSEcCtD
Salicylic acid—Asthma—Methotrexate—esophageal cancer	9.56e-05	0.0112	CcSEcCtD
Salicylic acid—Anorexia—Cisplatin—esophageal cancer	9.44e-05	0.0111	CcSEcCtD
Salicylic acid—Abdominal discomfort—Methotrexate—esophageal cancer	9.17e-05	0.0108	CcSEcCtD
Salicylic acid—Erythema—Capecitabine—esophageal cancer	8.95e-05	0.0105	CcSEcCtD
Salicylic acid—Dysgeusia—Capecitabine—esophageal cancer	8.76e-05	0.0103	CcSEcCtD
Salicylic acid—Decreased appetite—Cisplatin—esophageal cancer	8.61e-05	0.0101	CcSEcCtD
Salicylic acid—Drowsiness—Methotrexate—esophageal cancer	8.52e-05	0.01	CcSEcCtD
Salicylic acid—Pain—Cisplatin—esophageal cancer	8.47e-05	0.00997	CcSEcCtD
Salicylic acid—Feeling abnormal—Cisplatin—esophageal cancer	8.16e-05	0.00961	CcSEcCtD
Salicylic acid—Epistaxis—Methotrexate—esophageal cancer	8.04e-05	0.00946	CcSEcCtD
Salicylic acid—Hepatitis—Methotrexate—esophageal cancer	7.65e-05	0.009	CcSEcCtD
Salicylic acid—Confusional state—Capecitabine—esophageal cancer	7.36e-05	0.00866	CcSEcCtD
Salicylic acid—Oedema—Capecitabine—esophageal cancer	7.3e-05	0.00859	CcSEcCtD
Salicylic acid—Erythema multiforme—Methotrexate—esophageal cancer	7.24e-05	0.00851	CcSEcCtD
Salicylic acid—Tinnitus—Methotrexate—esophageal cancer	7.14e-05	0.0084	CcSEcCtD
Salicylic acid—Anorexia—Capecitabine—esophageal cancer	6.96e-05	0.00819	CcSEcCtD
Salicylic acid—Diarrhoea—Cisplatin—esophageal cancer	6.78e-05	0.00798	CcSEcCtD
Salicylic acid—Erythema—Methotrexate—esophageal cancer	6.66e-05	0.00784	CcSEcCtD
Salicylic acid—Dysgeusia—Methotrexate—esophageal cancer	6.52e-05	0.00768	CcSEcCtD
Salicylic acid—Dyspepsia—Capecitabine—esophageal cancer	6.43e-05	0.00756	CcSEcCtD
Salicylic acid—Decreased appetite—Capecitabine—esophageal cancer	6.35e-05	0.00747	CcSEcCtD
Salicylic acid—Vomiting—Cisplatin—esophageal cancer	6.3e-05	0.00741	CcSEcCtD
Salicylic acid—Rash—Cisplatin—esophageal cancer	6.25e-05	0.00735	CcSEcCtD
Salicylic acid—Pain—Capecitabine—esophageal cancer	6.25e-05	0.00735	CcSEcCtD
Salicylic acid—Constipation—Capecitabine—esophageal cancer	6.25e-05	0.00735	CcSEcCtD
Salicylic acid—Dermatitis—Cisplatin—esophageal cancer	6.24e-05	0.00734	CcSEcCtD
Salicylic acid—Feeling abnormal—Capecitabine—esophageal cancer	6.02e-05	0.00708	CcSEcCtD
Salicylic acid—Nausea—Cisplatin—esophageal cancer	5.89e-05	0.00692	CcSEcCtD
Salicylic acid—Urticaria—Capecitabine—esophageal cancer	5.8e-05	0.00683	CcSEcCtD
Salicylic acid—Confusional state—Methotrexate—esophageal cancer	5.48e-05	0.00645	CcSEcCtD
Salicylic acid—Anorexia—Methotrexate—esophageal cancer	5.18e-05	0.0061	CcSEcCtD
Salicylic acid—Pruritus—Capecitabine—esophageal cancer	5.17e-05	0.00608	CcSEcCtD
Salicylic acid—Diarrhoea—Capecitabine—esophageal cancer	5e-05	0.00588	CcSEcCtD
Salicylic acid—Somnolence—Methotrexate—esophageal cancer	4.83e-05	0.00569	CcSEcCtD
Salicylic acid—Dizziness—Capecitabine—esophageal cancer	4.83e-05	0.00568	CcSEcCtD
Salicylic acid—Dyspepsia—Methotrexate—esophageal cancer	4.79e-05	0.00563	CcSEcCtD
Salicylic acid—Decreased appetite—Methotrexate—esophageal cancer	4.73e-05	0.00556	CcSEcCtD
Salicylic acid—Pain—Methotrexate—esophageal cancer	4.65e-05	0.00547	CcSEcCtD
Salicylic acid—Vomiting—Capecitabine—esophageal cancer	4.64e-05	0.00546	CcSEcCtD
Salicylic acid—Rash—Capecitabine—esophageal cancer	4.61e-05	0.00542	CcSEcCtD
Salicylic acid—Dermatitis—Capecitabine—esophageal cancer	4.6e-05	0.00541	CcSEcCtD
Salicylic acid—Headache—Capecitabine—esophageal cancer	4.58e-05	0.00538	CcSEcCtD
Salicylic acid—Feeling abnormal—Methotrexate—esophageal cancer	4.48e-05	0.00527	CcSEcCtD
Salicylic acid—Nausea—Capecitabine—esophageal cancer	4.34e-05	0.0051	CcSEcCtD
Salicylic acid—Urticaria—Methotrexate—esophageal cancer	4.32e-05	0.00508	CcSEcCtD
Salicylic acid—Pruritus—Methotrexate—esophageal cancer	3.85e-05	0.00453	CcSEcCtD
Salicylic acid—Diarrhoea—Methotrexate—esophageal cancer	3.72e-05	0.00438	CcSEcCtD
Salicylic acid—Dizziness—Methotrexate—esophageal cancer	3.6e-05	0.00423	CcSEcCtD
Salicylic acid—Vomiting—Methotrexate—esophageal cancer	3.46e-05	0.00407	CcSEcCtD
Salicylic acid—Rash—Methotrexate—esophageal cancer	3.43e-05	0.00403	CcSEcCtD
Salicylic acid—Dermatitis—Methotrexate—esophageal cancer	3.42e-05	0.00403	CcSEcCtD
Salicylic acid—Headache—Methotrexate—esophageal cancer	3.41e-05	0.00401	CcSEcCtD
Salicylic acid—Nausea—Methotrexate—esophageal cancer	3.23e-05	0.0038	CcSEcCtD
Salicylic acid—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	2.15e-05	0.000301	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—NOS3—esophageal cancer	2.15e-05	0.000301	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.15e-05	0.0003	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.14e-05	0.000299	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.14e-05	0.000299	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.13e-05	0.000298	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BLVRB—esophageal cancer	2.13e-05	0.000297	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.13e-05	0.000297	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—HMOX1—esophageal cancer	2.09e-05	0.000292	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—TPI1—esophageal cancer	2.07e-05	0.000289	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTO1—esophageal cancer	2.07e-05	0.000289	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CA1—esophageal cancer	2.06e-05	0.000288	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC10A2—esophageal cancer	2.06e-05	0.000288	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CDKN1A—esophageal cancer	2.05e-05	0.000287	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.05e-05	0.000286	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CREBBP—esophageal cancer	2.01e-05	0.000281	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ELMO1—esophageal cancer	2.01e-05	0.00028	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ABCB1—esophageal cancer	2.01e-05	0.00028	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.99e-05	0.000277	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.99e-05	0.000277	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALDOB—esophageal cancer	1.98e-05	0.000277	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTGS2—esophageal cancer	1.97e-05	0.000275	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GSTO1—esophageal cancer	1.96e-05	0.000274	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TPI1—esophageal cancer	1.96e-05	0.000274	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EP300—esophageal cancer	1.95e-05	0.000273	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GAPDH—esophageal cancer	1.91e-05	0.000267	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ADH1B—esophageal cancer	1.9e-05	0.000266	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CRABP1—esophageal cancer	1.89e-05	0.000264	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CA2—esophageal cancer	1.89e-05	0.000264	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ALDOB—esophageal cancer	1.88e-05	0.000263	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.86e-05	0.000259	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.84e-05	0.000258	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.84e-05	0.000256	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TYMP—esophageal cancer	1.82e-05	0.000254	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HIST1H2BM—esophageal cancer	1.81e-05	0.000253	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GAPDH—esophageal cancer	1.81e-05	0.000253	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CA1—esophageal cancer	1.81e-05	0.000253	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.81e-05	0.000253	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GNG7—esophageal cancer	1.8e-05	0.000252	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NOS3—esophageal cancer	1.8e-05	0.000251	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.78e-05	0.000249	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.78e-05	0.000249	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.78e-05	0.000248	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP26A1—esophageal cancer	1.77e-05	0.000247	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PLCE1—esophageal cancer	1.75e-05	0.000245	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ADH7—esophageal cancer	1.75e-05	0.000245	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.74e-05	0.000244	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.74e-05	0.000244	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.73e-05	0.000242	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALOX15—esophageal cancer	1.72e-05	0.000241	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—ABL1—esophageal cancer	1.72e-05	0.000241	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—esophageal cancer	1.7e-05	0.000238	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.69e-05	0.000236	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CA1—esophageal cancer	1.69e-05	0.000236	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALDH2—esophageal cancer	1.69e-05	0.000236	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ERBB2—esophageal cancer	1.68e-05	0.000235	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EGFR—esophageal cancer	1.67e-05	0.000233	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—PIK3CA—esophageal cancer	1.67e-05	0.000233	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CA2—esophageal cancer	1.65e-05	0.000231	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTO1—esophageal cancer	1.64e-05	0.00023	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TPI1—esophageal cancer	1.64e-05	0.00023	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—EP300—esophageal cancer	1.64e-05	0.000229	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—esophageal cancer	1.61e-05	0.000225	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTT1—esophageal cancer	1.61e-05	0.000224	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—XIAP—esophageal cancer	1.6e-05	0.000223	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP2A6—esophageal cancer	1.59e-05	0.000222	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.58e-05	0.000221	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.58e-05	0.00022	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALDOB—esophageal cancer	1.58e-05	0.00022	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CA2—esophageal cancer	1.54e-05	0.000216	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ADH1B—esophageal cancer	1.54e-05	0.000215	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PLCE1—esophageal cancer	1.54e-05	0.000215	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ADH7—esophageal cancer	1.54e-05	0.000215	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.52e-05	0.000213	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GAPDH—esophageal cancer	1.52e-05	0.000212	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.51e-05	0.000211	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.51e-05	0.000211	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.5e-05	0.00021	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ENO1—esophageal cancer	1.5e-05	0.00021	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CRABP1—esophageal cancer	1.5e-05	0.00021	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—B2M—esophageal cancer	1.49e-05	0.000208	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCND1—esophageal cancer	1.49e-05	0.000208	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSME2—esophageal cancer	1.48e-05	0.000207	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSME1—esophageal cancer	1.48e-05	0.000207	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TYMP—esophageal cancer	1.47e-05	0.000205	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.46e-05	0.000205	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.45e-05	0.000203	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PIK3CA—esophageal cancer	1.45e-05	0.000202	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.44e-05	0.000202	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CDKN1A—esophageal cancer	1.44e-05	0.000201	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.44e-05	0.000201	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ADH7—esophageal cancer	1.44e-05	0.000201	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP26A1—esophageal cancer	1.43e-05	0.0002	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GNG7—esophageal cancer	1.43e-05	0.0002	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ENO1—esophageal cancer	1.43e-05	0.000199	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.42e-05	0.000198	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSME1—esophageal cancer	1.41e-05	0.000196	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSME2—esophageal cancer	1.41e-05	0.000196	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALOX15—esophageal cancer	1.39e-05	0.000195	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EP300—esophageal cancer	1.37e-05	0.000191	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CALR—esophageal cancer	1.35e-05	0.000188	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ADH1B—esophageal cancer	1.35e-05	0.000188	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CREBBP—esophageal cancer	1.34e-05	0.000187	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALDH2—esophageal cancer	1.34e-05	0.000187	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TPI1—esophageal cancer	1.33e-05	0.000186	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTO1—esophageal cancer	1.33e-05	0.000186	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.32e-05	0.000184	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FBXW7—esophageal cancer	1.3e-05	0.000182	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.29e-05	0.000181	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TYMP—esophageal cancer	1.29e-05	0.00018	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.28e-05	0.000179	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALDOB—esophageal cancer	1.27e-05	0.000178	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTT1—esophageal cancer	1.27e-05	0.000178	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.26e-05	0.000177	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.26e-05	0.000176	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.26e-05	0.000176	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.25e-05	0.000175	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.25e-05	0.000175	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NOS2—esophageal cancer	1.24e-05	0.000173	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.24e-05	0.000173	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GAPDH—esophageal cancer	1.23e-05	0.000171	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALOX15—esophageal cancer	1.22e-05	0.000171	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CRABP1—esophageal cancer	1.22e-05	0.00017	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CA—esophageal cancer	1.21e-05	0.000169	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TYMP—esophageal cancer	1.2e-05	0.000168	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.2e-05	0.000168	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—NOS3—esophageal cancer	1.2e-05	0.000168	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ENO1—esophageal cancer	1.19e-05	0.000167	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTGS1—esophageal cancer	1.19e-05	0.000167	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—esophageal cancer	1.19e-05	0.000167	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSME2—esophageal cancer	1.18e-05	0.000164	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSME1—esophageal cancer	1.18e-05	0.000164	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.17e-05	0.000164	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—esophageal cancer	1.17e-05	0.000163	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TPI1—esophageal cancer	1.17e-05	0.000163	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTO1—esophageal cancer	1.17e-05	0.000163	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GNG7—esophageal cancer	1.16e-05	0.000162	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.14e-05	0.000159	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALDOB—esophageal cancer	1.12e-05	0.000156	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CREBBP—esophageal cancer	1.12e-05	0.000156	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—HMOX1—esophageal cancer	1.1e-05	0.000153	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—esophageal cancer	1.1e-05	0.000153	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TPI1—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALDH2—esophageal cancer	1.08e-05	0.000151	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.08e-05	0.00015	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GAPDH—esophageal cancer	1.08e-05	0.00015	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.07e-05	0.00015	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CRABP1—esophageal cancer	1.07e-05	0.000149	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFBR2—esophageal cancer	1.05e-05	0.000147	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ABCB1—esophageal cancer	1.05e-05	0.000147	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.04e-05	0.000146	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.04e-05	0.000145	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTT1—esophageal cancer	1.03e-05	0.000144	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2A6—esophageal cancer	1.02e-05	0.000142	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.02e-05	0.000142	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.02e-05	0.000142	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GNG7—esophageal cancer	1.01e-05	0.000142	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—esophageal cancer	1.01e-05	0.000141	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GAPDH—esophageal cancer	1e-05	0.00014	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SMAD4—esophageal cancer	9.98e-06	0.000139	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NOS3—esophageal cancer	9.98e-06	0.000139	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.95e-06	0.000139	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—esophageal cancer	9.79e-06	0.000137	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS1—esophageal cancer	9.66e-06	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ENO1—esophageal cancer	9.66e-06	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.65e-06	0.000135	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP19A1—esophageal cancer	9.55e-06	0.000133	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSME2—esophageal cancer	9.52e-06	0.000133	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSME1—esophageal cancer	9.52e-06	0.000133	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALDH2—esophageal cancer	9.5e-06	0.000133	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GNG7—esophageal cancer	9.47e-06	0.000132	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—EP300—esophageal cancer	9.13e-06	0.000127	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTT1—esophageal cancer	9.03e-06	0.000126	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2A6—esophageal cancer	8.93e-06	0.000125	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.87e-06	0.000124	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—HMOX1—esophageal cancer	8.71e-06	0.000122	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.55e-06	0.000119	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS1—esophageal cancer	8.46e-06	0.000118	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ENO1—esophageal cancer	8.46e-06	0.000118	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.46e-06	0.000118	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.44e-06	0.000118	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ABCB1—esophageal cancer	8.36e-06	0.000117	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2A6—esophageal cancer	8.34e-06	0.000117	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSME2—esophageal cancer	8.34e-06	0.000117	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSME1—esophageal cancer	8.34e-06	0.000117	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.31e-06	0.000116	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.31e-06	0.000116	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP1B1—esophageal cancer	8.21e-06	0.000115	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HIF1A—esophageal cancer	8.17e-06	0.000114	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.96e-06	0.000111	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.91e-06	0.00011	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ENO1—esophageal cancer	7.91e-06	0.00011	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSME2—esophageal cancer	7.79e-06	0.000109	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSME1—esophageal cancer	7.79e-06	0.000109	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP19A1—esophageal cancer	7.72e-06	0.000108	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—EP300—esophageal cancer	7.59e-06	0.000106	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOS2—esophageal cancer	7.43e-06	0.000104	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOTCH1—esophageal cancer	7.36e-06	0.000103	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP1B1—esophageal cancer	7.2e-06	0.000101	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HMOX1—esophageal cancer	7.05e-06	9.84e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CREBBP—esophageal cancer	7.04e-06	9.83e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.91e-06	9.66e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.8e-06	9.5e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP19A1—esophageal cancer	6.77e-06	9.45e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCB1—esophageal cancer	6.76e-06	9.45e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—esophageal cancer	6.75e-06	9.43e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.72e-06	9.39e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CREBBP—esophageal cancer	6.67e-06	9.32e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.32e-06	8.83e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.32e-06	8.83e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NOS3—esophageal cancer	6.3e-06	8.8e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HMOX1—esophageal cancer	6.18e-06	8.63e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOS3—esophageal cancer	5.97e-06	8.34e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.77e-06	8.06e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—esophageal cancer	5.76e-06	8.05e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.66e-06	7.9e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—esophageal cancer	5.62e-06	7.85e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CREBBP—esophageal cancer	5.59e-06	7.81e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—esophageal cancer	5.59e-06	7.81e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.54e-06	7.73e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—esophageal cancer	5.43e-06	7.59e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.11e-06	7.14e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NOS3—esophageal cancer	5e-06	6.99e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—EP300—esophageal cancer	4.79e-06	6.7e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1A—esophageal cancer	4.78e-06	6.67e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EP300—esophageal cancer	4.54e-06	6.35e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CREBBP—esophageal cancer	4.52e-06	6.31e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.19e-06	5.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NOS3—esophageal cancer	4.05e-06	5.65e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CREBBP—esophageal cancer	3.96e-06	5.53e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—esophageal cancer	3.96e-06	5.53e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—esophageal cancer	3.87e-06	5.41e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—EP300—esophageal cancer	3.81e-06	5.32e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—esophageal cancer	3.7e-06	5.17e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.7e-06	5.17e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NOS3—esophageal cancer	3.55e-06	4.95e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—esophageal cancer	3.55e-06	4.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—esophageal cancer	3.36e-06	4.7e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NOS3—esophageal cancer	3.31e-06	4.63e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—esophageal cancer	3.24e-06	4.53e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—EP300—esophageal cancer	3.08e-06	4.3e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.03e-06	4.23e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—esophageal cancer	2.82e-06	3.93e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—EP300—esophageal cancer	2.7e-06	3.77e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—EP300—esophageal cancer	2.52e-06	3.52e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—esophageal cancer	2.28e-06	3.18e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—esophageal cancer	2e-06	2.79e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.86e-06	2.6e-05	CbGpPWpGaD
